Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.

Pneumocystis carinii pneumonia is often the terminal event for patients with the acquired immunodeficiency syndrome. Eflornithine (DL-alpha-difluoromethylornithine [DFMO]; Ornidyl; Merrell Dow Research Institute, Cincinnati, Ohio) has been used successfully against this protozoan disease in limited...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Clarkson, A B, Williams, D E, Rosenberg, C
Natura: Artigo
Lingua:Inglês
Pubblicazione: 1988
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC172369/
https://ncbi.nlm.nih.gov/pubmed/3142346
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi